BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 13, 2007
View Archived Issues
CHF-1512 effective in fluctuating Parkinson's disease
Read More
Recent patents disclose novel antidiabetic agents
Read More
Sirion raises financing to advance pipeline
Read More
New agents for treating Alzheimer's disease imparted in recent Pfizer patent
Read More
WAY-258131, a novel BACE-1 inhibitor with in vivo activity in mouse models of Alzheimer's disease
Read More
Studies support use of doripenem in urinary tract, intra-abdominal infections
Read More
PZ-601 pharmacokinetics assessed in healthy male volunteers
Read More
Hepatitis B surface antigen/1018-ISS combination shows promise
Read More
Selective beta3-adrenoceptor agonists with reduced cardiac side effects reported by Lilly
Read More
Endo receives notices from Anesiva regarding Zingo
Read More
AEE-788 inhibits human hepatocellular carcinoma in vitro and in vivo
Read More
Ditropan to be reviewed by FDA
Read More
sanofi-aventis reports novel therapeutic agents for renal disorders
Read More
FDA Arthritis Advisory Committee meets to discuss Arcoxia
Read More
Cryptopharma selects CP-92 for development in cystic fibrosis
Read More
Repligen licenses Friedreich's ataxia compounds from Scripps Institute
Read More
Xyotax has fast track designation for PS2 women with advanced NSCLC
Read More
Extended release formulation of the 5-HT1A antagonist AV-965 well tolerated in phase I trials
Read More
Rigel updates R-788 program
Read More
FDA extends review for eprodisate NDA
Read More
Pro-Pharmaceuticals receives FDA letter regarding Davanat/5-FU NDA
Read More
ADX-48621 begins phase I for depression, anxiety disorder and pain
Read More
New phase IIb study of pafuramidine maleate for malaria
Read More
Preliminary phase IIa findings for IPL-455903
Read More
Lpath closes first tranche of equity financing
Read More
EGIS-1150 effectively controls positive and negative schizophrenia symptoms in vivo
Read More
New data indicate higher virologic response with celgosivir combination therapy
Read More
Altabax approved for topical treatment of impetigo
Read More
Eisai withdraws European application for Aricept in severe Alzheimer's disease
Read More